Cytosorbents
CTSO
#10787
Rank
S$23.48 M
Marketcap
S$7.45
Share price
21.46%
Change (1 day)
694.69%
Change (1 year)

Earnings for Cytosorbents (CTSO)

Earnings in 2026 (TTM): -S$23.97 Million

According to Cytosorbents's latest financial reports the company's current earnings are S$37.21 Million. In 2025 the company made an earning of -S$11 Million, an increase over its 2024 earnings that were of -S$29.06 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Cytosorbents from 2006 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -S$23.97 Million118%
2025 -S$11 Million-62.16%
2024 -S$29.06 Million-22.49%
2023 -S$37.49 Million-13.52%
2022 -S$43.35 Million34.04%
2021 -S$32.34 Million182.17%
2020 -S$11.47 Million-55.97%
2019 -S$26.03 Million14.17%
2018 -S$22.8 Million95.14%
2017 -S$11.69 Million-22.32%
2016 -S$15.04 Million39.1%
2015 -S$10.82 Million-12.89%
2014 -S$12.42 Million89%
2013 -S$6.57 Million26.65%
2012 -S$5.19 Million-26.02%
2011 -S$7.01 Million-288.45%
2010 S$3.71 M-4.17%
2009 S$3.88 M-287.19%
2008 -S$2.08 Million-47.12%
2007 -S$3.93 Million41.78%
2006 -S$2.77 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Boston Scientific
BSX
S$4.78 B-20,203.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Hologic
HOLX
S$0.99 B-4,277.50%๐Ÿ‡บ๐Ÿ‡ธ USA
Meridian Bioscience
VIVO.defunct
S$70.96 M-398.19%๐Ÿ‡บ๐Ÿ‡ธ USA